Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca

Clinical trial NCT00349466 · COMPLETED

Trial details

NCT number: NCT00349466
Sponsor: Can-Fite BioPharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Keratoconjunctivitis Sicca

Start date: 2007-01-01
Primary completion: 2009-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.